These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 9135523)
1. Effects of sulindac on sporadic colorectal adenomatous polyps. Matsuhashi N; Nakajima A; Fukushima Y; Yazaki Y; Oka T Gut; 1997 Mar; 40(3):344-9. PubMed ID: 9135523 [TBL] [Abstract][Full Text] [Related]
2. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp. Matsuhashi N; Nakajima A; Shinohara K; Oka T; Yazaki Y Am J Gastroenterol; 1998 Nov; 93(11):2261-6. PubMed ID: 9820411 [TBL] [Abstract][Full Text] [Related]
3. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis. Hisamuddin IM; Wehbi MA; Schmotzer B; Easley KA; Hylind LM; Giardiello FM; Yang VW Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2366-9. PubMed ID: 16214918 [TBL] [Abstract][Full Text] [Related]
5. NSAID effect on sporadic colon polyps. Hixson LJ; Earnest DL; Fennerty MB; Sampliner RE Am J Gastroenterol; 1993 Oct; 88(10):1652-6. PubMed ID: 8213705 [TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer? Tonelli F; Valanzano R; Messerini L; Ficari F J Surg Oncol; 2000 May; 74(1):15-20. PubMed ID: 10861602 [TBL] [Abstract][Full Text] [Related]
7. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis. Winde G; Schmid KW; Brandt B; Müller O; Osswald H Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110 [TBL] [Abstract][Full Text] [Related]
8. [Role of suindac in the treatment of familial adenomatous polyposis coli]. Landauer S; Halimi C; Caulin C; Bergmann JF Therapie; 1999; 54(6):675-82. PubMed ID: 10709439 [TBL] [Abstract][Full Text] [Related]
9. Primary chemoprevention of familial adenomatous polyposis with sulindac. Giardiello FM; Yang VW; Hylind LM; Krush AJ; Petersen GM; Trimbath JD; Piantadosi S; Garrett E; Geiman DE; Hubbard W; Offerhaus GJ; Hamilton SR N Engl J Med; 2002 Apr; 346(14):1054-9. PubMed ID: 11932472 [TBL] [Abstract][Full Text] [Related]
10. [Treatment with sulindac of adenomatous polyps in familial polyposis]. Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106 [TBL] [Abstract][Full Text] [Related]
11. Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Guldenschuh I; Hurlimann R; Muller A; Ammann R; Mullhaupt B; Dobbie Z; Zala GF; Flury R; Seelentag W; Roth J; Meyenberger C; Fried M; Hoppeler T; Spigelman AD; Scott RJ Dis Colon Rectum; 2001 Aug; 44(8):1090-7; discussion 1097-9. PubMed ID: 11535846 [TBL] [Abstract][Full Text] [Related]
13. Sulindac for periampullary polyps in FAP patients. Richard CS; Berk T; Bapat BV; Haber G; Cohen Z; Gallinger S Int J Colorectal Dis; 1997; 12(1):14-8. PubMed ID: 9112144 [TBL] [Abstract][Full Text] [Related]
14. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857 [TBL] [Abstract][Full Text] [Related]
15. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Keller JJ; Offerhaus GJ; Polak M; Goodman SN; Zahurak ML; Hylind LM; Hamilton SR; Giardiello FM Gut; 1999 Dec; 45(6):822-8. PubMed ID: 10562579 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colorectal cancer: two steps forward, one step back? Half EE; Arber N Future Oncol; 2006 Dec; 2(6):697-704. PubMed ID: 17155896 [TBL] [Abstract][Full Text] [Related]
17. Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial. Samadder NJ; Kuwada SK; Boucher KM; Byrne K; Kanth P; Samowitz W; Jones D; Tavtigian SV; Westover M; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Burt RW; Neklason DW JAMA Oncol; 2018 May; 4(5):671-677. PubMed ID: 29423501 [TBL] [Abstract][Full Text] [Related]
18. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. Giardiello FM; Hamilton SR; Krush AJ; Piantadosi S; Hylind LM; Celano P; Booker SV; Robinson CR; Offerhaus GJ N Engl J Med; 1993 May; 328(18):1313-6. PubMed ID: 8385741 [TBL] [Abstract][Full Text] [Related]
19. Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis. Matsumoto T; Nakamura S; Esaki M; Yao T; Iida M J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):251-7. PubMed ID: 16460482 [TBL] [Abstract][Full Text] [Related]